GlassScriptPhysician profile
David J Lauber
NPI 1104879519
$1,168.70
in general payments reported to CMS, 2019-2025
29 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $92.77 · 2021: $148 · 2022: $100 · 2023: $235 · 2024: $338 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $136.21 | 2021-2025 | |
| Ethicon US, LLC | $108.73 | 2020-2023 | Echelon Flex, Harmonic, Surgicel Nu-Knit |
| Smith+Nephew, INC. | $102.54 | 2019-2025 | Stravix |
| Davol INC. | $94.48 | 2019-2025 | Arista, Avitene Ultrafoam |
| Takeda Pharmaceuticals U.S.A., INC. | $75.36 | 2022-2023 | Gattex |
| Medtronic, INC. | $73.93 | 2024 | Progrip |
| Intuitive Surgical, INC. | $64.55 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $55.89 | 2024-2025 | |
| Royal Biologics, INC. | $49.49 | 2024 | |
| Baxter Healthcare | $47.10 | 2024 | Tisseel |
| Pacira Pharmaceuticals Incorporated | $35.64 | 2021 | |
| Molli Surgical (US) INC | $27.71 | 2023 | |
| Merck Sharp & Dohme LLC | $26.54 | 2023 | Lynparza, Keytruda |
| Melinta Therapeutics, LLC | $24.38 | 2019 | |
| Teleflex LLC | $22.66 | 2024 | Deknatel |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $22.10 | 2025 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $21.67 | 2024 | Nuzyra |
| Kci USA, INC. | $19.47 | 2023 | Prevena, V.A.C. Veraflo |
| Aroa Biosurgery Incorporated | $18.50 | 2023 | |
| Phathom Pharmaceuticals, INC. | $17.66 | 2024 | Voquezna |
| Organogenesis INC. | $17.33 | 2021 | |
| Heron Therapeutics, INC. | $16.25 | 2023 | Zynrelef |
| Conmed Corporation | $15.24 | 2024 | Airseal |
| Cardinal Health 414 LLC | $13.49 | 2019 | |
| Lilly USA, LLC | $13.40 | 2024 | Verzenio |
| Ambu INC. | $12.94 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.40 | 2021 | |
| Boston Scientific Corporation | $11.88 | 2022 | |
| Puma Biotechnology, INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lauber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.